INmune Bio Inc (NASDAQ: INMB) is 56.75% higher on its value in year-to-date trading and has touched a low of $4.32 and a high of $12.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The INMB stock was last observed hovering at around $7.31 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $7.32, the stock is -3.68% and -9.47% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.17 million and changing 0.14% at the moment leaves the stock 8.21% off its SMA200. INMB registered -20.00% loss for a year compared to 6-month gain of 51.55%. The firm has a 50-day simple moving average (SMA 50) of $8.0861 and a 200-day simple moving average (SMA200) of $6.76455.
The stock witnessed a -11.91% loss in the last 1 month and extending the period to 3 months gives it a 8.93%, and is 8.77% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.62% over the week and 9.50% over the month.
INmune Bio Inc (INMB) has around 22 employees, a market worth around $167.85M and $0.01M in sales. Profit margin for the company is -300585.71%. Distance from 52-week low is 69.44% and -42.45% from its 52-week high. The company has generated returns on investments over the last 12 months (-130.12%).
The EPS is expected to grow by 15.41% this year, but quarterly earnings will post 64,757.14% year-over-year. Quarterly sales are estimated to shrink -100.00% in year-over-year returns.
101.0 institutions hold shares in INmune Bio Inc (INMB), with institutional investors hold 39.07% of the company’s shares. The shares outstanding are 22.28M, and float is at 16.30M with Short Float at 37.18%. Institutions hold 28.22% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 0.81 million shares valued at $7.17 million. The investor’s holdings represent 4.2103 of the INMB Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.63 million shares valued at $5.54 million to account for 3.4854 of the shares outstanding. The other top investors are CVI HOLDINGS, LLC which holds 0.6 million shares representing 3.0888 and valued at over $5.26 million, while PRAETORIAN PR LLC holds 2.512 of the shares totaling 0.48 million with a market value of $4.28 million.
INmune Bio Inc (INMB) Insider Activity
The most recent transaction is an insider purchase by Moss David J, the company’s Chief Financial Officer. SEC filings show that Moss David J bought 10,000 shares of the company’s common stock on Sep 30 ’24 at a price of $5.29 per share for a total of $52868.0. Following the purchase, the insider now owns 1.29 million shares.
INmune Bio Inc disclosed in a document filed with the SEC on Sep 12 ’24 that Tesi Raymond Joseph (President and CEO) bought a total of 15,380 shares of the company’s common stock. The trade occurred on Sep 12 ’24 and was made at $6.38 per share for $98048.0. Following the transaction, the insider now directly holds 1.55 million shares of the INMB stock.
Still, SEC filings show that on Sep 12 ’24, Moss David J (Chief Financial Officer) acquired 7,690 shares at an average price of $6.38 for $49024.0. The insider now directly holds 1,275,869 shares of INmune Bio Inc (INMB).
